The mechanism by which many of these gene alterations influence AMD risk remains unclear, although it is suspected that these variants may alter the integrity of BrM [195] or cause ECM protein accumulation in BrM as drusen [198]. This evidence concerns the gene SMARCA2 and age-related macular degeneration.